This page will host Events plug-in for all Clarion and trade events.

Upcoming Events

Astria Therapeutics to Present at Upcoming Cantor Global Healthcare Conference

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Cantor Global Healthcare Conference on Thursday, September 4 at 3:20pm ET.

A webcast of the presentation can be accessed at the following link: https://sqps.onstreamsecure.com/origin/enliven/players/EnlivenPlayer.html?customerId=22&eventId=98838667&checkCompany=1&checkEmail=1&checkName=1. An archived replay of the presentation will be available in the investors section of www.astriatx.com for 30 days following the event.

About Astria Therapeutics:

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by allergic and immunologic diseases. Our lead program, navenibart (STAR-0215), is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Our second program, STAR-0310, is an investigational monoclonal antibody OX40 antagonist in clinical development for the treatment of atopic dermatitis. Learn more about our company on our website, www.astriatx.com, or follow us on Instagram @AstriaTx and on Facebook and LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  219.22
-2.81 (-1.27%)
AAPL  261.11
-1.66 (-0.63%)
AMD  237.15
-0.88 (-0.37%)
BAC  51.15
-0.37 (-0.72%)
GOOG  254.59
+3.25 (1.30%)
META  732.43
-0.84 (-0.11%)
MSFT  520.29
+2.63 (0.51%)
NVDA  181.29
+0.13 (0.07%)
ORCL  273.86
-1.29 (-0.47%)
TSLA  445.36
+2.76 (0.62%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.